{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:30:32Z","timestamp":1792798232017,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR-45\/51\/2018-NAN-BMS"],"award-info":[{"award-number":["ICMR-45\/51\/2018-NAN-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.mehy.2019.109518","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T12:27:31Z","timestamp":1575635251000},"page":"109518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Sirolimus loaded polyol modified liposomes for the treatment of Posterior Segment Eye Diseases"],"prefix":"10.1016","volume":"136","author":[{"given":"Reshal","family":"Suri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yub Raj","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mehy.2019.109518_b0005","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.mehy.2019.109518_b0010","first-page":"42","article-title":"Uveitis: pathogenesis, clinical presentations and treatment","volume":"4","author":"Mustafa","year":"2014","journal-title":"IOSR J Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0015","series-title":"Age-related macular degeneration","author":"Holz","year":"2012"},{"key":"10.1016\/j.mehy.2019.109518_b0020","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2019.109518_b0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1742-1241.2006.01211.x","article-title":"Diabetic macular oedema: a clinical overview","volume":"61","author":"Girach","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.mehy.2019.109518_b0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archophthalmol.2009.58","article-title":"Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments","volume":"127","author":"Rein","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.mehy.2019.109518_b0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/IAE.0000000000000301","article-title":"Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials","volume":"35","author":"Chen","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.mehy.2019.109518_b0040","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2019.109518_b0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd3745","article-title":"Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.mehy.2019.109518_b0050","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00125-002-0990-7","article-title":"Diabetic retinopathy","volume":"45","author":"Porta","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2019.109518_b0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"Fagerness","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.mehy.2019.109518_b0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mehy.2019.109518_b0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4155\/tde-2017-0097","article-title":"Posterior drug delivery via periocular route: challenges and opportunities","volume":"8","author":"Waite","year":"2017","journal-title":"Ther Deliv"},{"key":"10.1016\/j.mehy.2019.109518_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)80602-9","article-title":"Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice","volume":"98","author":"Weng","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2019.109518_b0075","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00417-016-3398-7","article-title":"Rhegmatogenous retinal detachment following intravitreal ocriplasmin","volume":"254","author":"Madi","year":"2016","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.mehy.2019.109518_b0080","doi-asserted-by":"crossref","first-page":"20534","DOI":"10.1074\/jbc.M611782200","article-title":"Hypoxia-inducible factor 1\u00ce\u00b1 is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif","volume":"282","author":"Land","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.109518_b0085","first-page":"38","article-title":"Sirolimus in treatment of retinal diseases","author":"Dugel","year":"2009","journal-title":"Retina Today"},{"key":"10.1016\/j.mehy.2019.109518_b0090","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2019.109518_b0095","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1152\/japplphysiol.01197.2001","article-title":"Retinal venous oxygen saturation and cardiac output during controlled hemorrhage and resuscitation","volume":"94","author":"Denninghoff","year":"2003","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.mehy.2019.109518_b0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.mehy.2019.109518_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/863734","article-title":"Recent applications of liposomes in ophthalmic drug delivery","volume":"2011","author":"Mishra","year":"2011","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.mehy.2019.109518_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0169-409X(95)00016-Z","article-title":"Liposome ocular delivery systems","volume":"16","author":"Meisner","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2019.109518_b0115","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/j.1755-3768.2010.02008.x","article-title":"Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma","volume":"88","author":"Sachdeva","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.mehy.2019.109518_b0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2004.02.024","article-title":"Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes","volume":"276","author":"El Maghraby","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.colsurfb.2014.03.010","article-title":"Molecular arrangements and interconnected bilayer formation induced by alcohol or polyalcohol in phospholipid vesicles","volume":"117","author":"Manca","year":"2014","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.mehy.2019.109518_b0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0301-4622(99)00081-2","article-title":"Effects of alcohols on lipid bilayers with and without cholesterol: the dipalmitoylphosphatidylcholine system","volume":"81","author":"Rosser","year":"1999","journal-title":"Biophys Chem"},{"key":"10.1016\/j.mehy.2019.109518_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.08.034","article-title":"Effect of diclofenac and glycol intercalation on structural assembly of phospholipid lamellar vesicles","volume":"456","author":"Castangia","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.fct.2018.01.017","article-title":"Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule","volume":"113","author":"Kaddah","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.mehy.2019.109518_b0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/gerona\/glw090","article-title":"Rapamycin: an InhibiTOR of aging emerges from the soil of Easter Island","volume":"71","author":"Arriola Apelo","year":"2016","journal-title":"J Gerontol Ser A: Biomed Sci Med Sci"},{"key":"10.1016\/j.mehy.2019.109518_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mehy.2018.06.004","article-title":"mTOR inhibitors for treatment of low-risk prostate cancer","volume":"117","author":"Liss","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109518_b0155","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.mehy.2011.07.004","article-title":"mTORC1 activity as a determinant of cancer risk \u2013 rationalizing the cancer-preventive effects of adiponectin, metformin, rapamycin, and low-protein vegan diets","volume":"77","author":"McCarty","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109518_b0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mehy.2013.06.017","article-title":"Rapamycin and mTOR inhibitors probably have therapeutic effects for post-operative cognitive dysfunction","volume":"81","author":"Yang","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109518_b0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.mehy.2015.05.016","article-title":"Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations","volume":"85","author":"Colletti","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109518_b0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mehy.2016.08.008","article-title":"Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent","volume":"95","author":"Tomuli\u0107","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109518_b0175","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.mehy.2007.05.055","article-title":"Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?","volume":"70","author":"Zhao","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109518_b0180","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajpath.2012.04.018","article-title":"Prevention of age-related macular degeneration-like retinopathy by rapamycin in Rats","volume":"181","author":"Kolosova","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2019.109518_b0185","article-title":"Low dose rapamycin exacerbates autoimmune experimental uveitis","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2019.109518_b0190","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/IAE.0b013e3181e7978e","article-title":"A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization","volume":"30","author":"Nussenblatt","year":"2010","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1016\/j.mehy.2019.109518_b0195","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1167\/iovs.13-11650","article-title":"Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I\/II clinical trial","volume":"54","author":"Wong","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2019.109518_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21691401.2017.1408123","article-title":"Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies","volume":"46","author":"Haeri","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.mehy.2019.109518_b0205","article-title":"Solubilization of rapamycin, 213 INTL","volume":"25","author":"Simamora","year":"2001","journal-title":"J Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0210","doi-asserted-by":"crossref","first-page":"B101","DOI":"10.1016\/S0149-2918(00)89027-X","article-title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","author":"MacDonald","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.mehy.2019.109518_b0215","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00003088-200140080-00002","article-title":"Clinical pharmacokinetics of sirolimus","volume":"40","author":"Mahalati","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.mehy.2019.109518_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1473","article-title":"Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases","volume":"10","author":"Bisht","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.mehy.2019.109518_b0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/21691401.2014.953633","article-title":"Application of liposomes in medicine and drug delivery","volume":"44","author":"Daraee","year":"2016","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.mehy.2019.109518_b0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2018.12.015","article-title":"Gelatinized core liposomes: a new Trojan horse for the development of a novel timolol maleate glaucoma medication","volume":"556","author":"Hathout","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0235","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1021\/acs.molpharmaceut.8b00516","article-title":"Encapsulation of azithromycin ion pair in liposome for enhancing ocular delivery and therapeutic efficacy on dry eye","volume":"15","author":"Ren","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.colsurfb.2015.06.036","article-title":"Liposomal voriconazole (VOR) formulation for improved ocular delivery","volume":"133","author":"de S\u00e1","year":"2015","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.mehy.2019.109518_b0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(99)00192-3","article-title":"Acyclovir-containing liposomes for potential ocular delivery: corneal penetration and absorption","volume":"63","author":"Law","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.mehy.2019.109518_b0250","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1189\/jlb.0108076","article-title":"Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide","volume":"83","author":"Sun","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mehy.2019.109518_b0255","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.mehy.2019.109518_b0260","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1167\/iovs.09-4373","article-title":"Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes","volume":"51","author":"Zhang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2019.109518_b0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejps.2014.04.018","article-title":"Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes","volume":"62","author":"Lajunen","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.mehy.2019.109518_b0270","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1248\/yakushi.12-00234-3","article-title":"Non-invasive ophthalmic liposomes for nucleic acid delivery to posterior segment of eye","volume":"132","author":"Takashima","year":"2012","journal-title":"Yakugaku zasshi: J Pharm Soc Jpn"},{"key":"10.1016\/j.mehy.2019.109518_b0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2015.02.028","article-title":"Light induced cytosolic drug delivery from liposomes with gold nanoparticles","volume":"203","author":"Lajunen","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.mehy.2019.109518_b0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2013.07.060","article-title":"Glycerosomes: a new tool for effective dermal and transdermal drug delivery","volume":"455","author":"Manca","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.colsurfb.2017.05.049","article-title":"Proglycosomes: a novel nano-vesicle for ocular delivery of tacrolimus","volume":"157","author":"Garg","year":"2017","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.mehy.2019.109518_b0290","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/03639045.2011.553618","article-title":"The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems","volume":"37","author":"Sun","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.mehy.2019.109518_b0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/ps040440","article-title":"An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E da-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine","volume":"4","author":"Johnson","year":"2002","journal-title":"AAPS Pharmsci"},{"key":"10.1016\/j.mehy.2019.109518_b0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2006.01.020","article-title":"Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies","volume":"313","author":"Shen","year":"2006","journal-title":"Int J Pharm"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719311053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719311053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:20:29Z","timestamp":1759692029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719311053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":60,"alternative-id":["S0306987719311053"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109518","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus loaded polyol modified liposomes for the treatment of Posterior Segment Eye Diseases","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109518"}}